ethyl 3,4-bis(2-methoxyethoxy)benzoate,
183322-16-9,
3,4-Bis(2-methoxyethoxy)benzoic acid ethyl ester,
Benzoic acid, 3,4-bis(2-methoxyethoxy)-, ethyl ester,
AK-47966,
C15H22O6,
Erlotinib Impurity 17,
AC1MDC6N,
KSC496Q7J,
SCHEMBL263238,
CTK3J6874,
KS-00000BVO,
DTXSID40384593,
VGFZRAVMWXHEJB-UHFFFAOYSA-N,
BCP26355,
ZINC4324147,
ANW-54624,
CCG-41047,
CE-351,
CE0071,
MFCD01935284,
AKOS000282910,
AC-8521,
AM84636,
AN-7906,
Ethyl3,4-Bis(2-methoxyethoxy)benzoate,
MCULE-9544880239,
RTC-071177,
TRA0079293,
ACM183322169,
AJ-50609,
AS-11436,
CJ-11923,
SC-22536,
SY033195,
AB0009937,
AB1006719,
AX8128528,
DB-065438,
TC-071177,
E1186,
FT-0656916,
ST24046896,
MFCD01935284 (97%),
322E169,
A812767,
I01-1242,
SR-01000631149-1,
3,4-bis-(2-methoxy-ethoxy)-benzoic acid ethyl ester,
ZINC04324147,
ACN-032359,
CID2808992,
EC 605-991-9,
enzoic acid, 3,4-bis(2-methoxyethoxy)-, ethyl ester,